Hi, what are you looking for?
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
Pairing the psychedelic substance with a serotonin blocker could greatly expand its clinical use, according to new research from the University of Pittsburgh.
A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy
Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program
After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments